Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sleep Apnea cardioVascular Endpoints Study - Investigating the Effectiveness of Treatment With CPAP vs Standard Care in Reducing CV Morbidity and Mortality in Patients With Co-existing CV Disease and Moderate-severe Obstructive Sleep Apnea.

NCT00738179 is registered in ClinicalTrials.gov with Adelaide Institute for Sleep Health as lead sponsor.

NCT NCT00738179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00738179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sleep Apnea cardioVascular Endpoints Study - Investigating the Effectiveness of Treatment With CPAP vs Standard Care in Reducing CV Morbidity and Mortality in Patients With Co-existing CV Disease and Moderate-severe Obstructive Sleep Apnea.
Lead sponsor
Adelaide Institute for Sleep Health
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2008
Completion date
December 31, 2015
Enrollment
2,500 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, sleep apnea